1 / 7

You want me to participate in a HIV/AID Microbicidial Gel Trial?

Working for a healthier tomorrow. You want me to participate in a HIV/AID Microbicidial Gel Trial?. Informational Meeting-Clinical Study-HIV Microbicidial Gel Trial.

guy-jenkins
Télécharger la présentation

You want me to participate in a HIV/AID Microbicidial Gel Trial?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Working for a healthier tomorrow You want me to participate in a HIV/AID Microbicidial Gel Trial?

  2. Informational Meeting-Clinical Study-HIV Microbicidial Gel Trial • The purpose of this informational meeting is to recognize the strategies to reduce HIV/AIDS and promote the value of a healthy lifestyle. • The meeting will take place over a two-hour time period. • The meeting will inform potential participants about the benefits and risks associated with the Vaginal/Microbicidial Gel study for prevention against HIV.

  3. Pre-Clinical Screening

  4. Instructional Performance Objectives

  5. Tenofovir Microbicidial Gel for HIV • Teenage girls and young women, bear the brunt of the HIV epidemic in Africa • Tenofovir gel potentially adds a new approach to HIV prevention as the first that can be used and controlled by women. It could help empower women to take control of their own risk of HIV infection. • The CAPRISA 004 study is the first step - additional studies are urgently needed to confirm and extend the findings of the CAPRISA 004 trial • Once confirmed and implemented, tenofovir gel has the potential to alter the HIV epidemic. It is estimated that this gel could prevent 1.3 million new HIV infections and over 800,000 deaths in South Africa alone.

  6. Health Promotion Clinical StaffBreakout Group Session Participants will complete a short SMS Quiz at the end of the small group break out session. Study participants will be required to complete weekly surveys if they are accepted into the clinical trial.

  7. Thank You for Participating You want me to participate in a HIV/AID Microbicidial Gel Trial? http://www.fhi.org/en/Research/HIVAIDS_Prevention/CAPRISA004.htm http://www.mobileactive.org/case-studies/how-text-change-and-zain-used-mobile-quizzes-raise-hiv-aids-awareness

More Related